Pradia, Clouie L.
HRN: 21-88-65 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/20/2022
CO-AMOXICLAV 457MG/5ML, 70ML SUSPENSION (BOT)
09/13/2022
09/19/2022
PO
6ml
Tid
Uti
Waiting Final Action
Indication: Prophylaxis Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes